MID vs. CNCR ETF Comparison

Comparison of American Century Mid Cap Growth Impact ETF (MID) to Loncar Cancer Immunotherapy ETF (CNCR)
MID

American Century Mid Cap Growth Impact ETF

MID Description

The investment seeks long-term capital growth. The fund will invest principally in exchange-traded common stocks. Under normal market conditions, the portfolio managers will invest at least 80% of the fund's assets in securities of medium capitalization companies that the portfolio managers believe will create impact by aligning with at least one of the SDGs. The fund may purchase securities of small and large capitalization companies as well. It may engage in active and frequent trading of portfolio securities to achieve its principal investment strategies. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$56.62

Average Daily Volume

4,705

Number of Holdings *

34

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$15.86

Average Daily Volume

44,815

Number of Holdings *

71

* may have additional holdings in another (foreign) market
Performance
Period MID CNCR
30 Days -0.71% -0.06%
60 Days 0.11% -8.85%
90 Days 9.14% 8.50%
12 Months 30.19% 19.27%
0 Overlapping Holdings
Symbol Grade Weight in MID Weight in CNCR Overlap
MID Overweight 34 Positions Relative to CNCR
Symbol Grade Weight
MANH F 6.1%
CDNS D 5.67%
MPWR C 5.59%
RSG C 4.79%
VRT A 4.68%
MSCI F 4.14%
ESI C 4.01%
DXCM D 3.98%
AVNT A 3.83%
IQV D 3.8%
TT A 3.63%
ABNB D 3.6%
CMG A 3.58%
BFAM C 3.43%
DUOL A 2.94%
CHD B 2.89%
HUBB D 2.81%
KEYS D 2.78%
XYL A 2.63%
TECH C 2.53%
J B 2.45%
GEHC D 2.11%
INSP B 1.99%
ENPH F 1.98%
NTRA A 1.95%
EE B 1.93%
SWAV A 1.64%
ONON C 1.57%
PODD D 1.56%
ARGX D 1.5%
EFX D 0.99%
CNM A 0.98%
ALNY D 0.89%
VKTX C 0.75%
MID Underweight 71 Positions Relative to CNCR
Symbol Grade Weight
GERN B -3.05%
CGEM A -2.17%
ACRV B -2.12%
DCPH A -2.08%
ELVN B -2.05%
JANX A -2.01%
NUVB B -1.91%
DAWN A -1.63%
RVMD A -1.59%
TSVT D -1.52%
HCM B -1.46%
ITOS C -1.44%
YMAB C -1.44%
XNCR C -1.42%
BPMC A -1.41%
MRK B -1.4%
LYEL C -1.38%
MRUS C -1.38%
BCYC C -1.38%
TYRA C -1.35%
AURA D -1.34%
IPHA D -1.32%
ERAS D -1.31%
SMMT C -1.29%
MOR C -1.28%
PGEN D -1.28%
INBX D -1.28%
SDGR F -1.28%
IMCR D -1.28%
MGNX D -1.27%
FHTX D -1.27%
BNTX D -1.27%
EXEL D -1.27%
SNDX D -1.27%
RAPT F -1.27%
GLUE D -1.27%
VOR F -1.25%
SWTX D -1.24%
GMAB D -1.24%
REGN B -1.24%
NRIX D -1.22%
STRO F -1.22%
KURA D -1.21%
IGMS C -1.21%
KYMR D -1.2%
IDYA D -1.2%
IMTX D -1.18%
IOVA D -1.15%
RCUS F -1.11%
BMY F -1.1%
NUVL D -1.09%
PRLD D -1.09%
RLAY F -1.07%
ZNTL F -1.05%
KPTI F -1.05%
DNA F -1.04%
RXRX F -1.01%
ACLX D -0.98%
ACET F -0.97%
REPL F -0.96%
ARVN D -0.95%
AUTL F -0.92%
BMEA F -0.9%
CRBU F -0.9%
MRSN D -0.88%
LEGN F -0.87%
ALLO F -0.85%
RPTX F -0.83%
FATE D -0.74%
GNLX F -0.69%
IMRX F -0.69%
Compare ETFs